Heparin Market Size to Reach USD 15.58 Billion By 2032 | Astute Analytica [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
This change is a challenge for heparin producers as they will have to be flexible, creative and opportunistic to take different approaches towards anti-coagulant therapy. These abilities will decide where does heparin go next and whether or not it remains leader in multibillion-dollar industry. New Delhi, June 13, 2024 (GLOBE NEWSWIRE) -- The global heparin market was valued at US$ 10.76 billion in 2023 and is projected to surpass a valuation of US$ 15.58 billion by 2032 at a CAGR of 4.2% during the forecast period 2024–2032. The global demand for heparin is driven by its critical role in preventing and treating blood clots, particularly in patients undergoing surgery or dialysis, and those with cardiovascular diseases. China is the largest producer of heparin, contributing significantly to the global supply due to its extensive pig farming industry. The United States and Europe also play crucial roles in heparin production, with companies like Fresenius Kabi, Pfizer, and Sanofi b
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Is Pfizer's Pain Sarepta Therapeutics' Gain? Don't Bet on It. [Yahoo! Finance]Yahoo! Finance
- Moderna says its RSV shot is 50% effective after 18 months [CNBC]CNBC
- Obesity Pipeline Research 2024: Insights About 80+ Companies and 100+ Pipeline Drugs - Therapeutics Assessment by Product Type, Stage, Route of Administration, and Molecule Type [Yahoo! Finance]Yahoo! Finance
- Capvaxive will enhance protection against pneumococcal disease in older adults [Yahoo! Finance]Yahoo! Finance
- Meet The University College London (UCL) School Of Management MBA Class Of 2025 [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 6/17/24 - Form 4
- 6/17/24 - Form 4
- 6/11/24 - Form 11-K
- PFE's page on the SEC website